Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.79 |
| ▸ | USP2 | O75604 | 1/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.79 |
| ▸ | HPGD | P15428 | 1/20 | 0.79 |
| ▸ | FAP | Q12884 | 1/20 | 0.79 |
| ▸ | NR1I2 | O75469 | 5/20 | 0.66 |
| ▸ | HTR2C | P28335 | 1/20 | 0.66 |
| ▸ | PPARG | P37231 | 2/20 | 0.64 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.64 |
| ▸ | SLC22A8 | Q8TCC7 | 2/20 | 0.64 |
| ▸ | SLC22A11 | Q9NSA0 | 2/20 | 0.64 |
| ▸ | ALB | P02768 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.63 |
| ▸ | APEX1 | P27695 | 3/20 | 0.63 |
| ▸ | APAF1 | O14727 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cefditoren SCHEMBL27465513 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL16072829 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL27465514 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL157719 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL2925672 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL183495 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL13986532 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL183494 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL1650584 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL1650656 | 0.99 | MAPT (0.78) | MAPTALDH1A1USP2CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 12863 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637481-B2 | Boronic acid derivatives and therapeutic uses thereof | QPEX BIOPHARMA, INC. (US) | 2026-05-26 | — | — | US | claimed |
| EP-4739326-A2 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | SNIPR Biome ApS (DK) | 2026-05-13 | — | — | EP | claimed |
| US-20260115234-A1 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | SNIPR BIOME APS (DK) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-20260027140-A1 | COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA | ATOPIC MEDICAL INC (US) | 2026-01-29 | — | — | US | claimed |
| EP-4677075-A2 | TARGETING CELLS IN STRESSED GROWING CONDITIONS | SNIPR Biome ApS (DK) | 2026-01-14 | — | — | EP | claimed |
| EP-4658292-A1 | PRODUCTS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF PSEUDOMONAS INFECTIONS | The Administrators of The Tulane Educational Fund (US) | 2025-12-10 | — | — | EP | claimed |
| US-12465623-B2 | Use of parasites and extracellular vesicles obtained from parasites in cancer treatment | YEDITEPE UNIVERSITESI (TR) | 2025-11-11 | — | — | US | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| WO-2000061541-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2000-10-19 | — | — | WO | claimed |
| EP-0979229-A1 | 2-OXO-1-AZETIDINE SULFONIC ACID DERIVATIVES AS POTENT BETA-LACTAMASE INHIBITORS | Naeja Pharmaceutical Inc. (CA) | 2000-02-16 | — | — | EP | claimed |
| CN-1234036-A | Crystalline substance of cefditoren pivoxyl and prodn. of same | MEIJI SEIKA CO (JP) | 1999-11-03 | — | — | CN | claimed |
| US-5958915-A | MIXTURE OF CEFDITOREN PIVOXYL WITH A WATER SOLUBLE CASEIN SALT; REDUCED BITTER TASTE | MEIJI SEIKA KAISHA, LTD. (JP) | 1999-09-28 | — | — | US | claimed |
| EP-0937083-A1 | A CRYSTALLINE SUBSTANCE OF CEFDITOREN PIVOXIL AND THE PRODUCTION OF THE SAME | MEIJI SEIKA KAISHA LTD. (JP) | 1999-08-25 | — | — | EP | claimed |
| WO-1998047895-A1 | 2-OXO-1-AZETIDINE SULFONIC ACID DERIVATIVES AS POTENT β-LACTAMASE INHIBITORS | NAEJA PHARMACEUTICAL INC. (US) | 1998-10-29 | — | — | WO | claimed |
| EP-0862915-A1 | ANTIBACTERIAL COMPOSITION FOR ORAL ADMINISTRATION | MEIJI SEIKA KAISHA LTD. (JP) | 1998-09-09 | — | — | EP | claimed |
| WO-1998012200-A1 | A CRYSTALLINE SUBSTANCE OF CEFDITOREN PIVOXYL AND THE PRODUCTION OF THE SAME | MEIJI SEIKA KAISHA LTD. (JP) | 1998-03-26 | — | — | WO | claimed |
| US-5595986-A | Stably storable and readily water soluble composition of cephalosporin for injections | MEIJI SEIKA KAISHA, LTD. (JP) | 1997-01-21 | — | — | US | claimed |
| EP-0695548-A1 | A stably storable and readily water soluble composition of cephalosporin for injections | MEIJI SEIKA KAISHA LTD. (JP) | 1996-02-07 | — | — | EP | claimed |